喷昔洛韦（ penciclovir, PCV）为 20世纪 90年代问世的抗疱疹病毒药。于 1996年 6月在 英国首次上市。 1997年美国 31家医疗机构在 2 209例颜面单纯疱疹患者中进行的临床试验 表明，疗效明显优于对照基质 [1]。为了验证国产 1％喷昔洛韦乳膏局部外用对颜面单纯疱 疹的临床疗效 Penciclovir (PCV) is an anti-herpesvirus that came out in the 1990s. First listed in the UK in June 1996. Clinical trials conducted in 319 U.S. herpes simplex patients in 31 U.S. medical institutions in 1997 showed that the efficacy was significantly better than that of the control matrix [1]. In order to verify the topical 1% penciclovir cream topical herpes simplex clinical efficacy